ITGA2B and stroke disorder: A 30% reduction in composite vascular events (non fatal stroke, non-fatal myocardial infarction or death) and MI alone were seen when GP IIb/IIIa inhibitors were added to dual antiplatelet therapy in patients with NSTE-ACS (Table 2, Figures 2 and 3); a similar magnitude reduction in death was also present although this was non-significant due to the small number of events.